71 – 80 of 127
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Swedish National Guidelines on Urothelial Carcinoma : 2021 update on non-muscle invasive bladder cancer and upper tract urothelial carcinoma
- Contribution to journal › Article
-
Mark
Cost Effectiveness of the Use of Prophylactic Mesh To Prevent Parastomal Hernia After Urinary Diversion with an Ileal Conduit
- Contribution to journal › Article
-
Mark
Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer—A Narrative Review
- Contribution to journal › Scientific review
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
- Contribution to journal › Published meeting abstract
-
Mark
The Urothelial Transcriptomic Response to Interferon Gamma : Implications for Bladder Cancer Prognosis and Immunotherapy
- Contribution to journal › Article
-
Mark
Interaction between blood pressure and genetic risk score for bladder cancer, and risk of urothelial carcinoma in men
- Contribution to journal › Article
- 2021
-
Mark
When the Molecular Subtype Is Hidden Behind a Veil of Stroma
- Contribution to journal › Debate/Note/Editorial
-
Mark
Personalized medicine for bladder cancer
- Contribution to journal › Article
-
Mark
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
- Contribution to journal › Article
-
Mark
Tumor Subtyping : Making Sense of Heterogeneity with a Goal Toward Treatment
- Contribution to journal › Scientific review
